Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Capital Expenditures (2017 - 2025)

Catheter Precision has reported Capital Expenditures over the past 9 years, most recently at $10000.0 for Q2 2025.

  • Quarterly Capital Expenditures fell 77.78% to $10000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $17000.0 through Dec 2025, down 74.63% year-over-year, with the annual reading at $17000.0 for FY2025, 74.63% down from the prior year.
  • Capital Expenditures was $10000.0 for Q2 2025 at Catheter Precision, up from $7000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $148000.0 in Q3 2021 and troughed at -$207000.0 in Q4 2021.
  • The 5-year median for Capital Expenditures is $20000.0 (2021), against an average of $14923.1.
  • The largest YoY upside for Capital Expenditures was 543.48% in 2021 against a maximum downside of 4040.0% in 2021.
  • A 5-year view of Capital Expenditures shows it stood at -$207000.0 in 2021, then skyrocketed by 108.21% to $17000.0 in 2022, then grew by 5.88% to $18000.0 in 2023, then surged by 150.0% to $45000.0 in 2024, then crashed by 77.78% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Capital Expenditures are $10000.0 (Q2 2025), $7000.0 (Q1 2025), and $45000.0 (Q2 2024).